News
Obicetrapib monotherapy significantly improved the lipid profile of patients with heterozygous familial hypercholesterolemia ...
Aksh Ladegaonkar , a sophomore at International Baccalaureate at Bartow High School, earned second place in the Dr. Nelson ...
Regeneron Pharmaceuticals agreed to buy DNA testing company 23andMe in a bankruptcy court auction, the company said Monday.
The proposed transaction with Regeneron includes 23andMe’s personal genome service and total health and research services.
Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...
In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. A federal jury in Delaware ...
Meacham argues Regeneron's Eylea franchise and melanoma pipeline optionality leave it well-positioned, raising his price target to $700 from $600 after a roughly 55% stock pullback since last year ...
Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...
Regeneron Pharmaceuticals stock was among the ... writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with ...
Regeneron Pharmaceuticals Background Information (This description is provided by the company.) Regeneron is a leading biotechnology company that invents life-transforming medicines for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results